Literature DB >> 19660963

Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis.

Aramati B M Reddy1, Satish K Srivastava, Kota V Ramana.   

Abstract

AIM: Increased production of cytokines and chemokines in serum and tissues upon oxidative stress caused by severe systemic infections are the major cause of sepsis. Aldose reductase (AR) known to mediate oxidative stress-induced NF-kappaB activation and transcription of cytokines and chemokines are the main mediator of bacterial endotoxin-induced inflammatory response. Our aim is to investigate the effect of AR inhibitors on the prevention of inflammatory cytokines in the cecum ligation and puncture (CLP) model of polymicrobial sepsis which closely mimics the sepsis syndrome in humans.
RESULTS: Mice were rendered septic by CLP in the absence and presence of AR inhibitor, sorbinil. The levels of cytokines, chemokines and other inflammatory markers in the plasma, peritoneal fluid and heart of mice were significantly inhibited by sorbinil. Inhibition of AR also prevented CLP-induced COX-2, iNOS and HMGB-1 in heart, kidney and spleen.
CONCLUSIONS: Our results showed that the inhibition of AR significantly prevented the polymicrobial sepsis-induced increase in inflammatory markers and thus indicate the use of AR inhibitors as anti-inflammatory agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660963      PMCID: PMC2767443          DOI: 10.1016/j.cyto.2009.07.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  34 in total

Review 1.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

Review 2.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

Review 3.  The chronic consequences of severe sepsis.

Authors:  Claudia F Benjamim; Cory M Hogaboam; Steven L Kunkel
Journal:  J Leukoc Biol       Date:  2003-10-13       Impact factor: 4.962

4.  Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.

Authors:  Peter Q Eichacker; Chantal Parent; Andre Kalil; Claire Esposito; Xizhong Cui; Steven M Banks; Eric P Gerstenberger; Yvonne Fitz; Robert L Danner; Charles Natanson
Journal:  Am J Respir Crit Care Med       Date:  2002-11-01       Impact factor: 21.405

5.  Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.

Authors:  Kota V Ramana; Brian Friedrich; Sanjay Srivastava; Aruni Bhatnagar; Satish K Srivastava
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

6.  Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages.

Authors:  Kota V Ramana; Aramati B M Reddy; Ravinder Tammali; Satish K Srivastava
Journal:  Free Radic Biol Med       Date:  2007-01-24       Impact factor: 7.376

Review 7.  Antioxidants, NFkappaB activation, and diabetogenesis.

Authors:  E Ho; T M Bray
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

8.  Role of MCP-1 in endotoxemia and sepsis.

Authors:  Raina Devi Ramnath; Siaw Wei Ng; Angelo Guglielmotti; Madhav Bhatia
Journal:  Int Immunopharmacol       Date:  2008-03-18       Impact factor: 4.932

9.  Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells.

Authors:  Kota V Ramana; Deepak Chandra; Sanjay Srivastava; Aruni Bhatnagar; Bharat B Aggarwal; Satish K Srivastava
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

10.  Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis.

Authors:  Stefan Maier; Tobias Traeger; Markus Entleutner; Alexandra Westerholt; Britta Kleist; Norbert Hüser; Bernhard Holzmann; Albrecht Stier; Klaus Pfeffer; Claus-Dieter Heidecke
Journal:  Shock       Date:  2004-06       Impact factor: 3.454

View more
  19 in total

1.  Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages.

Authors:  Aramati B M Reddy; Satish K Srivastava; Kota V Ramana
Journal:  Int J Biochem Cell Biol       Date:  2010-03-27       Impact factor: 5.085

2.  Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.

Authors:  Chie Hayashi; Andres G Madrigal; Xinyan Liu; Takashi Ukai; Sulip Goswami; Cynthia V Gudino; Frank C Gibson; Caroline A Genco
Journal:  J Innate Immun       Date:  2010-05-10       Impact factor: 7.349

Review 3.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

4.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

Review 5.  Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.

Authors:  Satish K Srivastava; Umesh C S Yadav; Aramati B M Reddy; Ashish Saxena; Ravinder Tammali; Mohammad Shoeb; Naseem H Ansari; Aruni Bhatnagar; Mark J Petrash; Sanjay Srivastava; Kota V Ramana
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

6.  Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.

Authors:  Mohammad Shoeb; Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-08-05       Impact factor: 7.376

7.  Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.

Authors:  Umesh C S Yadav; Mohammad Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

8.  ALDOSE REDUCTASE: New Insights for an Old Enzyme.

Authors:  Kota V Ramana
Journal:  Biomol Concepts       Date:  2011-04-01

9.  Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages.

Authors:  Mahavir Singh; Aniruddh Kapoor; James McCracken; Bradford Hill; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2017-01-19       Impact factor: 5.192

10.  Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-κB pathway inhibition.

Authors:  Chien-Hung Lin; Chung-Ching Lin
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.